Systemic sclerosis (scleroderma): who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

• All targets
• CD19 46
• BCMA 25
• CD20 5
• JAK 0
• STAT3 0
• mTOR 0
• PPAR 0
• PD-1 1
• STING 0
• IL-17 0
• IL-6 0
• NLRP3 0
• CTLA-4 1
• CXCR4 0
• HMGB1 0
• IL-13 0
• IL-4 0
• NRF2 0
• PD-L1 1
• RUNX1 0
• SGLT2 0
• AKT 0
• CD123 0
• CD30 0
• CD38 1
• FGFR 0
• G6PD 0
• GLP-1 0
• HIF-1 0
• IL-15 1
• MMP-9 0
• PARP 0
• PI3K 0
• SIRT1 0
• TLR4 0
• TNF 0
• TP53 0
• TREM2 0
• TYK2 0

EU-13 is a filter, not a ranking: it only narrows the list.

1 of 1+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

• Withdrawn

  Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune Diseases

  NCT07361094· Beijing Boren Hospital· Updated 15 Oct 2026

  “No participants.”Registry text, quoted unchanged. Source

Trials whose registry record says individual participant data (IPD) will be shared.

• A Study of AZD0120 in Autoimmune Diseases

  NCT07295847· AstraZeneca· Source

• An Exploratory Clinical Study of SCAR02 Targeting BCMA and CD19 for the Treatment of Refractory Autoimmune Diseases

  NCT06503224· The First Affiliated Hospital of University of Science and Technology of China· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 10
• Mendelian Randomization Analysis 8
• Gene Expression Profiling 14
• Sequence Analysis, RNA 3
• Exome Sequencing 1
• Proteomics 11
• Metabolomics 6
• Mass Spectrometry 2
• Flow Cytometry 9
• Immunohistochemistry 2
• Positron-Emission Tomography 3
• Magnetic Resonance Imaging 26
• Machine Learning 7
• Deep Learning 3
• Cohort Studies 42
• Genome-Wide Association Study 13

See which targets of this disease your abstract mentions, and go to the people working on them.